Strides for Sarcoma
Research
Sarcoma is cancer of either the bone or connective tissue. Although it has over 70 subtypes, it remains one of the least funded cancers by a wide margin. Year over year, only 1% of cancer research funding is allocated to sarcomas. The harsh reality is sarcomas are rare and impact a smaller percentage of people each year which means a smaller percentage of funding is allocated to research vs other more prominent cancers. We believe that by donating to research we are one step closer to finding a cure.
In 2024, we were able to donate a total of $12,500 to three different sarcoma research labs at Indiana University School of Medicine. Below are more details about each lab!
Pollok Lab
Dr. Pollok is the Caroline Symmes Professor of Pediatric Cancer Research. She serves as Co-leader of the Experimental and Developmental Therapeutics Program and Director of the Preclinical Modeling and Therapeutics Core for the IU Simon Comprehensive Cancer Center.
Dr. Pollok’s team science-based program encompasses basic scientists and clinicians seeking cures for aggressive cancers such as sarcomas and brain tumors. They are using multi-omics data to prioritize testing of novel combination therapy and have developed >50 tumor models from pediatric and adolescent patients seen at the Riley Hospital for Children.
Greenfield Lab
The Greenfield Lab’s long-standing research interests focus on basic and translational aspects of bone biology, and on osteosarcoma metastasis.
The osteosarcoma project aims to repurpose FDA-approved drugs to block growth of lung metastases, which is the primary cause of lethality in osteosarcoma patients. Current studies utilize 3D sarcosphere cultures and mouse models.
